These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25796505)

  • 1. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
    Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
    Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.
    Weng M; Song F; Chen J; Wu J; Qin J; Jin T; Xu J
    Tumour Biol; 2015 Feb; 36(2):959-66. PubMed ID: 25315189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.
    Chen P; Wang XL; Ma ZS; Xu Z; Jia B; Ren J; Hu YX; Zhang QH; Ma TG; Yan BD; Yan QZ; Li YL; Li Z; Yu JY; Gao R; Fan N; Li B; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(7):3223-8. PubMed ID: 22994738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
    Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
    Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
    He J; Liu C; Wang B; Li N; Zuo G; Gao D
    Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.
    Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ
    J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
    Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
    Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
    Jiang N; Zhou LQ; Zhang XY
    Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.
    Ma Q; Wang X; Wang H; Song W; Wang Q; Wang J
    Biomed Res Int; 2020; 2020():8610271. PubMed ID: 32596388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
    Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
    DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Liu X; Ma W; Yan Y; Wu S
    J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
    Jiang W; Zheng J; Yu T; Wang J
    Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling.
    Gan Y; He L; Yao K; Tan J; Zeng Q; Dai Y; Liu J; Tang Y
    Oncol Lett; 2017 Dec; 14(6):6463-6470. PubMed ID: 29163683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.
    Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research advances in HMGN5 and cancer.
    Shi Z; Tang R; Wu D; Sun X
    Tumour Biol; 2016 Feb; 37(2):1531-9. PubMed ID: 26700674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGN5 expression in bladder cancer tissue and its role on prognosis.
    Wu J; Wang J
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):970-975. PubMed ID: 29509244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGN5: a potential oncogene in gliomas.
    Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
    J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ppGalNAc T1 as a potential novel marker for human bladder cancer.
    Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP
    Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.